Jingjie Biotech Unveils China's First At-Home Creatinine, Glucose, and Uric Acid Test Device – A Breakthrough in Kidney Health Management

Chronic Kidney Disease (CKD)High prevalence, low awareness, poor prognosis, and high medical costs have become major public health concerns worldwide. As renal function declines, patients with chronic kidney disease (CKD) face a significantly increased risk of cardiovascular events and mortality. Once CKD progresses to end-stage renal disease (ESRD), patients require dialysis or kidney transplantation to sustain life, imposing a substantial economic burden on their families and society.

Furthermore, there is a scarcity of devices on the market capable of rapidly and accurately assessing renal function. Patients can only determine their risk of kidney disease and monitor disease progression through biochemical testing. This limitation often results in inadequate early-stage management, leading to disease exacerbation.

To address the current issue,Nanjing Jingjie Biotechnology Co., Ltd.(hereinafter referred to as “Jingjie Technology”)Launch Innovative Products——Jingjie Shenkang Creatinine 5-in-1 Test Device ("Handheld Electrochemical Analyzer")，with the aim of helping patients with chronic kidney disease (CKD) and high-risk populations, such as those with hypertension, diabetes, and hyperuricemia, manage their kidney health at home, while also providing hospitals, communities, clinics, nursing homes, and other institutions with a convenient solution for kidney disease management.This product obtained the Medical Device Registration Certificate (Su Xie Zhu Zhun 20242220136) issued by the Jiangsu Provincial Medical Products Administration on January 23, 2024, and its accompanying “Creatinine Test Strips” also leveragedPioneeringSuccessfully approved as a Class II medical device in Jiangsu Province (Jiangsu Medical Device Registration No. 20242401111) and received FDA Breakthrough Device designation.

On Thursday, November 7, at 19:30, the 110th session of VCBeat New Product Showcase will feature Dr. Huang Baofu, Deputy General Manager of Jingjie Technology, and Zhang Xiangyu, Senior Medical Manager at Jingjie Technology, who will presentChina's First "Creatinine, Blood Glucose, and Uric Acid Tester"(Self-Testable) Product Promotion.

Jingjie Shenkang Creatinine 5-in-1 Analyzer

Scan the QR code on the poster to add the assistant and reserve a spot for the live broadcast.

Dr. Huang Baofu

Deputy General Manager of Jingjie Technology

Ph.D. in Microbiology from Zhejiang University, specializing in Microbiology. Senior IVD Product Expert. High-level Innovative and Entrepreneurial Talent of Jiangsu Province, Industrial Professor at Southeast University, and Deputy Secretary-General of the Jiangsu Provincial Association for Innovation and Entrepreneurship Talents. Over ten years of experience in the research, development, and management of in vitro diagnostic reagents and analytical instruments. Participated in projects funded by the National Natural Science Foundation of China and the National Key Basic Research Development Program (973 Program). Led one National Innovation Fund Project for Small and Medium-sized Enterprises and oversaw the establishment of two municipal-level engineering research centers. Contributed to 34 invention patents and 33 utility model patents.

Zhang Xiangyu

Senior Medical Manager at Jingjie Technology

Attending Physician, Master of Clinical Medicine. Graduated from Anhui Medical University, he previously served at the First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Wuhu Hospital Affiliated to East China Normal University, and Conch Hospital Affiliated to Anhui Medical University. He participated in one project funded by the National Natural Science Foundation of China and possesses solid medical expertise along with extensive clinical experience.

Nanjing Jingjie Biotechnology Co., Ltd. was established in 2018, bringing together leading talents from China and abroad in the fields of chemistry, materials science, electronics, and biomedical engineering. Adhering to the core values of “Quality, Innovation, Collaboration, and Responsibility,” the company continues to innovate in electrochemistry, microfluidics, signal acquisition, and automation technologies, dedicated to the research and development, production, and sales of precise POCT, health management products, and solutions.

Jingjie Technology has invested hundreds of millions of RMB to establish a research and development (R&D) and production base covering nearly 10,000 square meters in the Nanjing Jiangbei New Area. The facility includes internationally advanced R&D laboratories, GMP-compliant production workshops, and automated production lines. The company has successfully built three major technology platforms: a globally leading electrochemical detection technology platform, a high-sensitivity multi-channel signal acquisition and processing platform, and an integrated microfluidics and automated manufacturing platform. This achievement enables full domestic self-research and development across the entire process, from raw material sourcing to product application.

“VCBeat New Product Showcase” is a live-streaming series designed to support medical enterprises in launching their innovative products. The program’s mission is to facilitate the milestone launch of every innovative medical product. If your company has plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “VCBeat New Product Showcase,” please add our assistant for consultation.

Scan the QR code below to contact the assistant and schedule a live stream (if you have already added them, please reach out to the assistant directly).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Contact the assistant and send a screenshot of the live stream to enter the lucky draw for a chance to win a [15-day trial membership to VBInsight Industry Think Tank].